Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues
RGD peptides have received a lot of attention over the two last decades, in particular to improve tumor therapy through the targeting of the αVβ3 integrin receptor. This review focuses on the molecular design of multimeric RGD compounds, as well as the design of suitable linkers for drug delivery. M...
Main Authors: | Jordan Cossu, Fabien Thoreau, Didier Boturyn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/2/525 |
Similar Items
-
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation In Vitro
by: Hendrik Schneider, et al.
Published: (2021-07-01) -
PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin α<sub>v</sub>β<sub>3</sub> Receptors
by: Christos Liolios, et al.
Published: (2021-03-01) -
Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens
by: Hiroaki Echigo, et al.
Published: (2021-10-01) -
Multimerization Increases Tumor Enrichment of Peptide–Photosensitizer Conjugates
by: Jisi Zhao, et al.
Published: (2019-02-01) -
Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect
by: Liu H, et al.
Published: (2022-01-01)